0.5202
Dyadic International Inc De stock is traded at $0.5202, with a volume of 126.74K.
It is up +3.89% in the last 24 hours and down -51.83% over the past month.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
See More
Previous Close:
$0.5007
Open:
$0.5
24h Volume:
126.74K
Relative Volume:
0.37
Market Cap:
$20.84M
Revenue:
$3.81M
Net Income/Loss:
$-7.29M
P/E Ratio:
-2.432
EPS:
-0.2139
Net Cash Flow:
$-5.72M
1W Performance:
-15.29%
1M Performance:
-51.83%
6M Performance:
-36.87%
1Y Performance:
-45.64%
Dyadic International Inc De Stock (DYAI) Company Profile
Name
Dyadic International Inc De
Sector
Industry
Phone
561-743-8333
Address
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Compare DYAI vs PSNYW, GOODO, SHMD, DWLD, QQQE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.69 | 0 | 0 | 0 | 0 | 0.00 | |
|
PSNYW
Polestar Automotive Holding Uk
|
5.00 | 394.14M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.92 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.15 | 315.90M | 52.15M | -21.46M | 0 | -0.4675 |
|
DWLD
Davis Select Worldwide ETF
|
47.39 | 0 | 0 | 0 | 0 | 0.00 |
|
QQQE
Direxion NASDAQ-100 Equal Weigh
|
120.75 | 0 | 0 | 0 | 0 | 0.00 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Resumed | H.C. Wainwright | Buy |
| Sep-08-25 | Initiated | Craig Hallum | Buy |
| Jul-18-22 | Downgrade | Dawson James | Buy → Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
Dyadic International Inc De Stock (DYAI) Latest News
Dyadic International (DYAI) Q2 2026 Earnings Call Transcript - AOL.ca
Amylase Enzyme Cleaner Market Growth to 2035 Driven by Membrane Filtration DemandNews and Statistics - IndexBox
Llamada de resultados del T2 de 2026 de Dyadic International (DYAI): progreso comercial y riesgo de liquidez - TradingKey
Dyadic International Announces New Equity Financing Agreements - TipRanks
Dyadic International (DYAI) Ergebniskonferenz Q2 2026: Kommerzielle Fortschritte und Liquiditätsrisiko - TradingKey
Dyadic International Earnings Call: Promise Amid Cash Strain - TipRanks
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement - GlobeNewswire
Dyadic International Warns of Going-Concern Risk as Dilution, Nasdaq Uncertainty and Noteholder Dependence Threaten Shareholder Value - TipRanks
Dyadic International Q2 Results: EPS Misses Estimate, Sales Down 0.6% YoY - scanx.trade
Cellulase Silage Additives Market Growth to 2035 Driven by Asia-Pacific Livestock ExpansionNews and Statistics - IndexBox
Segmentation, Major Trends, and Competitive Overview of the Specialty Enzymes Market - openPR.com
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement - GlobeNewswire
Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026 - GlobeNewswire
Dyadic Delivers Two Bundibugyo Ebola Antigens for Preclinical Evaluation - Stock Titan
Form 4 Dyadic International Inc For: 25 July By Investing.com - Investing.com South Africa
Francisco trust disposes of $124,957 in Dyadic International stock By Investing.com - Investing.com Canada
Dyadic Regains Nasdaq Compliance, Secures Continued Listing - TipRanks
Dyadic regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Canada
Dyadic International, Inc. (DYAI) stock price, news, quote and history - Yahoo Finance Singapore
Dyadic Announces Continued Listing on the Nasdaq Capital Market - GlobeNewswire
Dyadic International (NASDAQ:DYAI) Share Price Crosses Above 50-Day Moving AverageShould You Sell? - MarketBeat
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program - GlobeNewswire
Bullish Charts & Commercial Breakthroughs For Florida Biomanufacturer Could Fuel Upwards Valuation - Streetwise Reports
Analysts Expect Breakeven For Dyadic International, Inc. (NASDAQ:DYAI) Before Long - simplywall.st
Dyadic International stock reflects a thin catalyst day. Focus stays on its enzyme platform. - ad-hoc-news.de
DYAIDyadic International Inc, DE Forecast, Target Price - Finviz
Food Enzymes Market Size, Share, Analysis & Trends, 2034 - Market Data Forecast
Enzyme Complex Digestive Market Forecast 2026-2035: Growth Driven by Feed Efficiency and Antibiotic ReductionNews and Statistics - IndexBox
Dyadic Shareholders Approve Reverse Split and Governance Proposals - TipRanks
An Interview with the President & COO: How Dyadic is Commercializing Its Protein Platform Across Multi-Billion-Dollar Markets - TradingView
Dyadic Faces Nasdaq Delisting Review After Compliance Failures - TipRanks
World Enzyme-Based Waste DegradationMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Dyadic Showcases C1 Platform Amid Ebola Preparedness Surge - TipRanks
World Amyloglucosidase EnzymeMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
De-Inking Enzymes Market is Booming Worldwide | Major Giants Megazyme, BASF SE, DuPont - openPR.com
Enzyme Stabilizer Market Trends Support A 6.7% CAGR Outlook Through The Forecast Period - openPR.com
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: BioHarvest Sciences (BHST) and Brown Forman A (BF.A) - The Globe and Mail
Dyadic Under $1 as Investors Eye June Vote - Bez Kabli
Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Vaxcyte (PCVX) and BeOne Medicines (ONC) - The Globe and Mail
Dyadic International Launches Recombinant Human Albumin and Bovine Chymosin - asatunews.co.id
Analysts Offer Insights on Industrial Goods Companies: DroneShield Limited (OtherDRSHF), CryoPort (CYRX) and Deere (DE) - The Globe and Mail
Dyadic International (DYAI) Surges 13.8% – Key Levels in FocusETF AUM Growth - newsline.com
Dyadic and Scripps Research Partner to Accelerate Hantavirus Antibody and Vaccine Development Using C1 Biologic Platform - Minichart
Skyline Corporate Communications Group, LLC Announces Dyadic Applied BioSolutions to Deliver a Live Presentation at the Skyline Signature Series™ on Wednesday, May 27 at 12:00 PM ET - GlobeNewswire Inc.
Skyline Corporate Communications Group, LLC Announces - GlobeNewswire
Dyadic International’s Earnings Call Shows Early Momentum - The Globe and Mail
Dyadic International Earnings Call Highlights Early Momentum - TipRanks
Earnings call transcript: Dyadic’s Q1 2026 revenue surges 182% despite EPS miss By Investing.com - Investing.com Australia
Earnings call transcript: Dyadic’s Q1 2026 revenue surges 182% despite EPS miss - Investing.com
Japan’s First LNG Shipment via Hormuz Since Strait’s De Facto Closure Marks Energy Security MilestoneAnalyst Coverage Count - The Legal Advocate
Dyadic International Inc De Stock (DYAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dyadic International Inc De Stock (DYAI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Francisco Trust under agreemen | 10% Owner |
Jul 22 '26 |
Sale |
1.33 |
38,016 |
50,481 |
3,337,648 |
| Francisco Trust under agreemen | 10% Owner |
Jul 24 '26 |
Sale |
1.21 |
2,616 |
3,173 |
3,280,272 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):